Bacteria are steadily becoming less and less responsive to currently available antibiotics. Together with members of the public, we explored the hot topic of ‘antimicrobial resistance’ at the European Researchers’ Night in Padua on 27 September 2019.
Penta will be present at the European Researchers’ Night in Padua on 27 September, 2019. For this edition we have chosen the theme of ‘antimicrobial resistance’ (AMR). With the help of flyers and an educational video we hope to illustrate to the public what ‘AMR’ is, how it develops and spreads, and raise awareness on how much this problem is threatening global health. Our team will point out some simple yet extremely important practices that can limit the progression of resistance.
We are delighted to see an article on children’s antibiotics, co-authored by GARDP R&D Director, Dr Seamus O’Brien, Penta’s Chief Scientific Officer, Prof. Theo Zakoutlis and Prof. Mike Sharland, from St. George’s, University of London, published in AMR Control, as governments have been discussing AMR at the World Health Assembly.
On Tuesday 24th September, the Infection Prevention Disease Society event IP2019 in Liverpool will host the one-day conference: Infection Prevention in Paediatrics: ‘Hand in Hand’- working together for children.
Penta have joined forces with GARDP (The Global Antibiotic Research & Development Partnership) to tackle drug-resistant infections in children. Our strategic collaboration aims to accelerate paediatric development of antibiotic treatments including: clinical trials designed to meet regulatory requirements; and trials with a focus on public health interventions to inform treatment guidelines.
Penta project manager Davide Bilardi, together with other NeoObs project partners, recently visited the neonatal units of the Santa Casa Hospital in São Paolo and the Clinical Research Unit of University of São Paolo in Ribeirao Preto. The visit occurred in the last week of January and was an opportunity to strengthen the relationship with new partner sites involved in the activities of this study.
We are pleased to celebrate the milestone achievement of the randomisation of 200 participants in the NeoVanc project. Congratulations to all the NeoVanc team!
On 18th and 19th December 2018 the 7th General Assembly and 4th Investigators meeting of NeoVanc project will take place in Athens, Greece.